» Articles » PMID: 39416925

Potential Application of Menadione for Antimicrobial Coating of Surgical Sutures

Overview
Date 2024 Oct 17
PMID 39416925
Authors
Affiliations
Soon will be listed here.
Abstract

Staphylococcal-associated surgical site infections (SSI) are common nosocomial infections in healthcare facilities worldwide. The use of antiseptic-coated sutures has been recommended to minimise the risk of SSI in clinical settings. However, as there has been a growing concern over antibiotic resistance resulting from antiseptic usage, development of antimicrobial sutures using alternative compounds is necessary. In this study, menadione (2-methyl-1,4-napthoquinone), also known as Vitamin K was evaluated as a potential antimicrobial compound for suture coating. The anti-staphylococcal activity of menadione was assessed using microbroth dilution method and biofilm inhibition assays. The low menadione minimum biofilm inhibitory concentration values against both methicillin-susceptible and -resistant strains indicate its inhibitory activity against staphylococcal biofilm. Menadione-coated sutures were prepared by dip-coating surgical sutures in slurries containing poly(D,L-lactide-co-glycolide) polymers (either 65:35 or 75:25) and calcium stearate. Zone of inhibition assays showed dose-dependent antimicrobial effects of the sutures up to four days. A ∼3 log10 colony forming unit/ml reduction of adherent bacteria (p < 0.05) on the sutures was demonstrated via bacterial adherence assays. The integrity and tensile strength of the sutures were unaffected by the coating procedure. In view of the increased antibiotic resistance and limited antimicrobials, menadione may be potentially useful for antimicrobial coating of surgical sutures.

Citing Articles

Menadione as Antibiotic Adjuvant Against : Mechanism of Action, Efficacy and Safety.

Shehu K, Schneider M, Kraegeloh A Antibiotics (Basel). 2025; 14(2).

PMID: 40001407 PMC: 11851977. DOI: 10.3390/antibiotics14020163.

References
1.
Selvaraj A, Jayasree T, Valliammai A, Pandian S . Myrtenol Attenuates MRSA Biofilm and Virulence by Suppressing Expression Dynamism. Front Microbiol. 2019; 10:2027. PMC: 6737500. DOI: 10.3389/fmicb.2019.02027. View

2.
Eriksen J, Kaalund I, Clemmensen O, Overgaard J, Pfeiffer P . Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash. Support Care Cancer. 2017; 25(7):2179-2185. DOI: 10.1007/s00520-017-3623-x. View

3.
Badia J, Casey A, Petrosillo N, Hudson P, Mitchell S, Crosby C . Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017; 96(1):1-15. DOI: 10.1016/j.jhin.2017.03.004. View

4.
Birhanu Y, Endalamaw A . Surgical site infection and pathogens in Ethiopia: a systematic review and meta-analysis. Patient Saf Surg. 2020; 14:7. PMC: 7035652. DOI: 10.1186/s13037-020-00232-y. View

5.
Schlievert P, Merriman J, Salgado-Pabon W, Mueller E, Spaulding A, Vu B . Menaquinone analogs inhibit growth of bacterial pathogens. Antimicrob Agents Chemother. 2013; 57(11):5432-7. PMC: 3811306. DOI: 10.1128/AAC.01279-13. View